BV can increase the risk of serious health, physical, and emotional consequences1-3

Bacterial vaginosis (BV) is associated with an increased risk of serious health complications for women and their partners3,4:

  • Increased risk of sexually transmitted infections (STIs), human immunodeficiency virus (HIV), and HIV transmission to sex partners
  • Increased risk of pelvic inflammatory disease (PID), which may affect fertility
  • Can lead to late fetal loss during pregnancy, premature birth, or low birth weight

76% of women would have gone to see their HCP sooner if they were aware of the risks associated with BV if left untreated.5*

woman writing in journal

In a patient survey, 68% of women with BV felt self-conscious and 66% felt embarrassed due to their condition.5*

Visit Next:

solosec oral granules packet


Solosec® (secnidazole) may help your patients complete treatment.

Find out how


Survey conducted online by Harris Poll on behalf of Symbiomix Therapeutics, LLC, a Lupin Company and the American Sexual Health Association (ASHA) within the United States between September 14 and 29, 2017 among 304 U.S. women aged 18-49 who have been diagnosed by a healthcare professional with bacterial vaginosis (BV) within the past 2 years ("women with bacterial vaginosis"). Figures for age, income, race/ethnicity, region, education, and size of household were weighted where necessary to bring them into line with their actual proportions in the population.5


  1. Chavoustie SE, Eder SE, Koltun WD, et al. Experts explore the state of bacterial vaginosis and the unmet needs facing women and providers. Int J Gynaecol Obstet. 2017;137:107-109.
  2. Bilardi J, Walker S, McNair R, et al. Women's management of recurrent bacterial vaginosis and experiences of clinical care: a qualitative study. PLoS One. 2016;11(3):e0151794. doi: 10.1371/journal.pone.0151794. eCollection 2016. Accessed August 23, 2017.
  3. Centers for Disease Control and Prevention. Bacterial vaginosis—CDC Fact Sheet. Accessed March 12, 2018.
  4. Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Investig. 2011;121(12):4610-4617.
  5. Data on File, Patient Research, Symbiomix, a Lupin Company. Prepared October 2017.